Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Azemiglitazone (MSDC 0602) is an insulin sensitizer potentially for the treatment of diabetes.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 12,000 | |||
10 mg | 在庫あり | ¥ 17,500 | |||
25 mg | 在庫あり | ¥ 37,500 | |||
50 mg | 在庫あり | ¥ 68,500 | |||
100 mg | 在庫あり | ¥ 126,000 | |||
500 mg | 在庫あり | ¥ 273,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | Azemiglitazone (MSDC 0602) is an insulin sensitizer potentially for the treatment of diabetes. |
別名 | MSDC 0602 |
分子量 | 371.41 |
分子式 | C19H17NO5S |
CAS No. | 1133819-87-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (336.56 mM), Sonication is recommended.
H2O: < 0.1 mg/mL (insoluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Azemiglitazone 1133819-87-0 Metabolism PI3K/Akt/mTOR signaling Mitochondrial Metabolism mTOR MSDC 0602 MSDC0602 MSDC-0602 inhibit Inhibitor inhibitor